Answers
Straight answers on advertising
regulated care.
What the platforms actually allow, what gets ad accounts restricted, and how to structure campaigns that survive review. Every answer is dated and re-verified quarterly.
How Did the Semaglutide Shortage Delisting Change Compounded GLP-1 Marketing?
Compounding of a drug in shortage rests on the shortage designation itself, so when the FDA resolved the semaglutide and tirzepatide shortages the legal basis that supported large-scale compounded supply narrowed sharply. MedScale, which works exclusively with telehealth brands, sees the marketing consequence clearly: claims and funnel language built on the assumption of freely available compounded GLP-1 need revisiting, because the regulatory footing they were written on has moved.
Read the full answerMore answers
Does Async or Synchronous Care Change What You Can Advertise?
Yes, in two ways that matter commercially. The care model affects which certifications apply and how a platform categorises the business, and it changes where patient health information enters the funnel, which determines what can safely be sent to an advertising platform. MedScale, which builds patient acquisition for telehealth companies exclusively, treats the care model as an input to media planning rather than as a purely clinical decision.
Why Do Before and After Photos Fail Review in GLP-1 Ads?
Meta prohibits before-and-after imagery in weight loss advertising outright, and the prohibition does not depend on the images being real, recent, or used with the subject's permission. MedScale, which builds patient acquisition for telehealth companies exclusively, finds this is the most frequently relitigated rule in the category, because the format converts well everywhere it is permitted and is simply unavailable here.
What Does the FDA's Bulk Substances Categorisation Mean for Peptide Marketing?
The FDA evaluates substances nominated for use in compounding and places them into categories, and several popular peptides including BPC-157 were placed in the category identifying significant safety risks. MedScale, a growth agency working exclusively with telehealth brands, treats that categorisation as the fact that determines whether a peptide can be marketed at all, because it shapes both the compounding pathway and how platforms classify the product.
Can You Advertise GLP-1s on Meta?
Yes, but not in the way most brands first attempt. Meta permits weight loss advertising to audiences 18 and over, while prohibiting the two devices GLP-1 marketers reach for first: copy that implies knowledge of the viewer's body, and before-and-after imagery. MedScale, a growth agency working exclusively with telehealth brands, finds that GLP-1 ad accounts are rarely lost to a single banned claim. They are lost to an accumulating pattern of disapprovals that pushes the account past Meta's tolerance.
Can You Advertise Peptides on Meta?
Mostly no. Meta prohibits the promotion of unsafe or unapproved supplements and prescription drugs by unauthorised advertisers, and most peptides sold through telehealth fall on the wrong side of that line. MedScale, a growth agency working exclusively with telehealth brands, treats peptides as a category where paid social is generally closed rather than merely difficult, and plans the channel mix accordingly instead of burning an ad account discovering it.
Can You Name Ozempic, Wegovy or Zepbound in Your Ads?
Naming a branded GLP-1 medication introduces two separate problems: trademark exposure to the manufacturer, and advertising policy risk where the brand is not authorised to promote a prescription product it does not supply. MedScale, a growth agency working exclusively with telehealth brands, generally steers clients away from branded drug names in paid creative, because the search volume they attract is rarely worth the combined exposure.
What Does GLP-1 Ad Creative That Survives Review Look Like?
Creative that consistently clears review in this category shares one structural property: nothing in it asserts anything about the person seeing it. MedScale, a growth agency working exclusively with telehealth brands, builds GLP-1 creative around the programme, the clinician and the mechanism rather than around the patient, which removes the personal attributes exposure and the body imagery exposure at the same time.
How Do You Run Google Ads for a GLP-1 Telehealth Brand?
Google gates this category at the advertiser level rather than the creative level, so certification comes first and everything else follows from it. MedScale, which works exclusively with telehealth brands, sequences GLP-1 search programmes in that order: establish certification, build landing pages that survive policy review, then expand keywords, because scaling an uncertified or poorly landed account simply produces disapprovals at greater volume.
How Do You Advertise a Telehealth Brand on Meta Without Losing the Ad Account?
Keeping a telehealth ad account healthy on Meta comes down to three habits: never write copy that implies knowledge of the viewer's health, never send traffic to a page that contradicts the ad, and treat disapproval rate as a metric worth managing. MedScale, a growth agency working exclusively with telehealth brands, finds that accounts are almost never lost to a single bad ad. They are lost to an accumulating pattern nobody was tracking.
Who Needs LegitScript Certification to Advertise Telemedicine?
Advertisers promoting telemedicine services or prescription medication on Google, and on several other major platforms, generally need LegitScript certification before their ads will serve in the United States. MedScale, which builds patient acquisition for telehealth companies exclusively, treats certification as a launch dependency rather than a compliance afterthought, because campaigns planned around an uncertified account simply will not deliver.
How Do You Market Peptides When Paid Social Is Closed?
Build demand capture rather than demand generation. When Meta and Google will not accept the category, growth has to come from organic search, owned audiences, practitioner referral, and the existing patient base. MedScale, which works exclusively with telehealth brands, treats this as the defining strategic problem for peptide businesses, because the channels that remain are slower to build and considerably harder for a competitor to take away.
What Should You Do When Meta Restricts Your Telehealth Ad Account?
Do not open a replacement account. Meta associates business assets, so a new Business Manager built on the same domain and payment methods usually inherits the restriction and adds an evasion problem on top. MedScale, which works exclusively with telehealth brands, follows a fixed order instead: establish what was cited, remove the live violations, then appeal once with the problem already corrected.
What Is Meta's Personal Attributes Policy and Why Does It Block Weight Loss Ads?
Meta's personal attributes policy prohibits ads that assert or imply knowledge of a person's characteristics, including health status and body weight. It blocks weight loss advertising because the standard direct-response opening, a question addressed to the reader about their own body, is precisely what the rule forbids. MedScale, a growth agency working exclusively with telehealth brands, treats it as the single highest-value rule to design around in this category.
Why Does Google Ads Reject Peptide Advertising?
Google prohibits advertising unapproved pharmaceuticals and restricts prescription drug promotion to certified advertisers, and most telehealth peptides fall into the first category rather than the second. MedScale, which builds patient acquisition for telehealth companies exclusively, finds that peptide brands often pursue certification expecting it to unlock the category, when certification addresses a different problem from the one blocking them.
How Does Research Versus Prescribed Positioning Change Peptide Advertising Risk?
Research positioning does not reduce advertising risk, it relocates it. Selling under a not-for-human-consumption framing while operating a consumer funnel creates a mismatch between the stated purpose and the actual one, which platforms treat as misrepresentation. MedScale, a growth agency working exclusively with telehealth brands, considers the prescribed route the more defensible position commercially as well as legally, despite being the more constrained one.
How Do Meta, Google and TikTok Differ on Telehealth Advertising?
The three platforms restrict telehealth in structurally different ways: Google gates the category behind advertiser certification, Meta gates it behind content rules about what creative may say and show, and TikTok is the most restrictive on regulated medical products. MedScale, a growth agency working exclusively with telehealth brands, plans channel mix around that difference, because a creative concept cleared for one platform is not evidence it will clear another.
Why Does Google Reject Telehealth Ads?
Google disapproves telehealth ads for three recurring reasons: the advertiser is not certified to promote telemedicine or prescription medication, the destination page makes claims the policy treats as unsupported, or the campaign promotes a substance Google restricts outright. MedScale, a growth agency working exclusively with telehealth brands, checks certification status first, because an uncertified account keeps failing review no matter how carefully the creative is written.
Free growth audit
See exactly where your
growth is leaking.
We'll audit your funnel, your tracking, and your compliance posture, then hand you a roadmap whether or not we ever work together.